How ToxVeritas Evaluates Evidence

---

Hazard evidence identifies the intrinsic potential of a substance, mixture, or exposure scenario to cause harm. Relevant endpoints may include:

• Genotoxicity and carcinogenicity
• Reproductive and developmental toxicity
• Target-organ and repeated-dose toxicity
• Local effects, sensitization, and irritation
• Toxicokinetics and mechanistic evidence

The presence of a hazard does not, by itself, establish unacceptable risk.

Dose-response evaluation examines how the incidence, magnitude, or severity of an effect changes with administered or internal dose. Relevant values may include:

• NOAELs, LOAELs, and benchmark doses
• Points of departure
• Permitted Daily Exposures
• Acceptable or Tolerable Daily Intakes
• Acceptable Intakes and TTC values

Each value is interpreted according to its source, purpose, population, exposure conditions, jurisdiction, and limitations.

Exposure assessment evaluates the amount, route, frequency, and duration of contact with a substance. It may consider:

• Product-use conditions and systemic availability
• Population characteristics
• Aggregate exposure across sources and routes
• Cumulative exposure, when relevant
• Assumptions, data gaps, and uncertainty

Risk characterization integrates hazard, dose-response, exposure, and uncertainty to determine the significance of a potential risk. Conclusions clearly distinguish:

• Scientific findings
• Regulatory requirements
• Exposure assumptions
• Health-based values
• Evidence-based interpretation
• Key uncertainties and data gaps

Where applicable, estimated exposure is compared with relevant health-based values, margins, and decision thresholds. Confidence in the conclusion and conditions that could change it are clearly identified.

Regulatory expectations vary by jurisdiction, product category, and stage of development. ToxVeritas identifies the applicable authority and distinguishes among:

• Binding legal requirements
• Final regulatory guidance
• Draft guidance and consultation documents
• Scientific opinions and technical recommendations
• Emerging policy directions and industry practices

Regulatory status, scientific relevance, and applicability are evaluated separately.

ToxVeritas prioritizes primary and authoritative sources, using Vancouver-style numbered references unless another format is more appropriate. Links are provided when publicly available.

Secondary sources may provide context but do not replace accessible primary or authoritative evidence. Content is identified as a targeted evidence review, professional commentary, or systematic review, as applicable.

Technology-assisted tools, including artificial intelligence, may support literature discovery, information organization, data extraction, and drafting. They do not independently determine scientific or regulatory conclusions. All published content is subject to expert review for scientific accuracy, source support, regulatory context, and clarity.

ToxVeritas content reflects an independent interpretation of publicly available evidence and does not represent the position of any employer, regulatory authority, professional organization, or other institution unless expressly stated.

Material conflicts of interest, sponsorships, or commercial relationships that could influence published content are disclosed when applicable.

ToxVeritas provides educational information, scientific commentary, and regulatory intelligence. Content is not a substitute for a product-specific toxicological risk assessment or professional regulatory, legal, or medical advice.

Conclusions may vary with the substance, formulation, exposure, population, jurisdiction, and intended use. Readers should consult original sources and qualified professionals before applying general information to a specific decision.